Camp4 Therapeutics Corporation (CAMP)

NASDAQ: CAMP · Real-Time Price · USD

3.250

-0.140 (-4.13%)

At close: Dec 5, 2025, 4:00 PM EST

3.310

+0.060 (1.85%)

After-hours: Dec 5, 2025, 5:14 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Regulatory Ribonucleic Acid-based Therapeutics	652.00K	Log In
Regulatory Ribonucleic Acid-based Therapeutics Growth	86.29%	Log In

Revenue by Geography

Fiscal year is January - December.